CARTA CIENTÍFICO-CLÍNICA
Reacción cutánea mano-pie por regorafenib
Hand-Foot Skin Reaction to Regorafenib
P. Espinosa Laraa,
, C. Bueno Muiñob, B. Doger de Spévilleb, J. Jiménez Reyesc
Autor para correspondencia
a Servicio de Dermatología, Unidad de Oncodermatología, Consulta de efectos adversos por antineoplásicos, Hospital Universitario Infanta Cristina, Parla, Madrid, España
b Servicio de Oncología Médica, Hospital Universitario Infanta Cristina, Parla, Madrid, España
c Servicio de Dermatología, Hospital Universitario Infanta Cristina, Parla, Madrid, España
Leído
9682
Vecesse ha leído el artículo
3007
Total PDF
6675
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 32 | 3 | 35 |
| 2025 5 | 152 | 41 | 193 |
| 2025 4 | 159 | 42 | 201 |
| 2025 3 | 178 | 29 | 207 |
| 2025 2 | 178 | 41 | 219 |
| 2025 1 | 132 | 29 | 161 |
| 2024 12 | 120 | 48 | 168 |
| 2024 11 | 150 | 68 | 218 |
| 2024 10 | 110 | 55 | 165 |
| 2024 9 | 132 | 49 | 181 |
| 2024 8 | 118 | 77 | 195 |
| 2024 7 | 132 | 56 | 188 |
| 2024 6 | 161 | 38 | 199 |
| 2024 5 | 114 | 30 | 144 |
| 2024 4 | 116 | 42 | 158 |
| 2024 3 | 104 | 53 | 157 |
| 2024 2 | 65 | 36 | 101 |
| 2024 1 | 91 | 32 | 123 |
| 2023 12 | 103 | 49 | 152 |
| 2023 11 | 85 | 44 | 129 |
| 2023 10 | 86 | 32 | 118 |
| 2023 9 | 81 | 36 | 117 |
| 2023 8 | 112 | 35 | 147 |
| 2023 7 | 146 | 40 | 186 |
| 2023 6 | 84 | 31 | 115 |
| 2023 5 | 243 | 43 | 286 |
| 2023 4 | 102 | 29 | 131 |
| 2023 3 | 107 | 31 | 138 |
| 2023 2 | 125 | 25 | 150 |
| 2022 1 | 101 | 37 | 138 |
| 2022 12 | 109 | 54 | 163 |
| 2022 11 | 95 | 55 | 150 |
| 2022 10 | 104 | 41 | 145 |
| 2022 9 | 123 | 55 | 178 |
| 2022 8 | 103 | 56 | 159 |
| 2022 7 | 98 | 62 | 160 |
| 2022 6 | 73 | 43 | 116 |
| 2022 5 | 80 | 51 | 131 |
| 2022 4 | 92 | 72 | 164 |
| 2022 3 | 86 | 65 | 151 |
| 2022 2 | 82 | 29 | 111 |
| 2021 1 | 114 | 48 | 162 |
| 2021 12 | 76 | 48 | 124 |
| 2021 11 | 77 | 41 | 118 |
| 2021 10 | 120 | 67 | 187 |
| 2021 9 | 78 | 60 | 138 |
| 2021 8 | 75 | 42 | 117 |
| 2021 7 | 66 | 81 | 147 |
| 2021 6 | 89 | 107 | 196 |
| 2021 5 | 71 | 76 | 147 |
| 2021 4 | 130 | 112 | 242 |
| 2021 3 | 117 | 47 | 164 |
| 2021 2 | 75 | 32 | 107 |
| 2020 1 | 73 | 38 | 111 |
| 2020 12 | 62 | 36 | 98 |
| 2020 11 | 58 | 34 | 92 |
| 2020 10 | 49 | 29 | 78 |
| 2020 9 | 68 | 23 | 91 |
| 2020 8 | 43 | 24 | 67 |
| 2020 7 | 44 | 21 | 65 |
| 2020 6 | 44 | 42 | 86 |
| 2020 5 | 42 | 37 | 79 |
| 2020 4 | 40 | 24 | 64 |
| 2020 3 | 35 | 18 | 53 |
| 2020 2 | 3 | 2 | 5 |
| 2020 1 | 0 | 7 | 7 |
| 2019 12 | 2 | 5 | 7 |
| 2019 11 | 0 | 3 | 3 |
| 2019 10 | 0 | 2 | 2 |
| 2019 9 | 6 | 1 | 7 |
| 2019 8 | 7 | 0 | 7 |
| 2019 7 | 1 | 2 | 3 |
| 2019 6 | 13 | 1 | 14 |
| 2019 5 | 1 | 9 | 10 |
| 2019 4 | 13 | 6 | 19 |
| 2019 3 | 3 | 4 | 7 |
| 2019 2 | 7 | 11 | 18 |
| 2019 1 | 3 | 0 | 3 |
| 2018 12 | 16 | 3 | 19 |
| 2018 11 | 6 | 3 | 9 |
| 2018 10 | 19 | 2 | 21 |
| 2018 9 | 44 | 2 | 46 |
| 2018 6 | 2 | 3 | 5 |
| 2018 5 | 0 | 4 | 4 |
| 2018 4 | 1 | 1 | 2 |
| 2018 3 | 1 | 1 | 2 |
| 2018 2 | 39 | 8 | 47 |
| 2018 1 | 72 | 16 | 88 |
| 2017 12 | 13 | 0 | 13 |
| 2017 11 | 10 | 0 | 10 |
| 2017 10 | 4 | 0 | 4 |
| 2017 9 | 5 | 1 | 6 |
| 2017 8 | 1 | 0 | 1 |
| 2017 7 | 3 | 0 | 3 |
| 2017 6 | 13 | 0 | 13 |
| 2017 5 | 2 | 1 | 3 |
| 2017 4 | 15 | 3 | 18 |
| 2017 3 | 3 | 0 | 3 |
| 2017 2 | 4 | 0 | 4 |
| 2016 1 | 3 | 1 | 4 |
| 2016 12 | 12 | 5 | 17 |
| 2016 11 | 7 | 1 | 8 |
| 2016 10 | 6 | 12 | 18 |
| 2016 9 | 0 | 5 | 5 |
| 2016 8 | 1 | 5 | 6 |
| 2016 7 | 4 | 5 | 9 |
| 2016 6 | 0 | 1 | 1 |
Mostrar todo
